{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T14:58:08Z","timestamp":1768748288466,"version":"3.49.0"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1097\/fpc.0000000000000140","type":"journal-article","created":{"date-parts":[[2015,4,8]],"date-time":"2015-04-08T04:20:19Z","timestamp":1428466819000},"page":"323-333","source":"Crossref","is-referenced-by-count":23,"title":["Genetic variants within the TNFRSF1B gene and susceptibility to rheumatoid arthritis and response to anti-TNF drugs"],"prefix":"10.1097","volume":"25","author":[{"given":"Luz M.","family":"Canet","sequence":"first","affiliation":[]},{"given":"Ileana","family":"Filipescu","sequence":"additional","affiliation":[]},{"given":"Rafael","family":"C\u00e1liz","sequence":"additional","affiliation":[]},{"given":"Carmen B.","family":"Lupia\u00f1ez","sequence":"additional","affiliation":[]},{"given":"Helena","family":"Canh\u00e3o","sequence":"additional","affiliation":[]},{"given":"Alejandro","family":"Escudero","sequence":"additional","affiliation":[]},{"given":"Juana","family":"Segura-Catena","sequence":"additional","affiliation":[]},{"given":"Mar\u00eda J.","family":"Soto-Pino","sequence":"additional","affiliation":[]},{"given":"Miguel A.","family":"Ferrer","sequence":"additional","affiliation":[]},{"given":"Antonio","family":"Garc\u00eda","sequence":"additional","affiliation":[]},{"given":"Lurdes","family":"Romani","sequence":"additional","affiliation":[]},{"given":"Eva","family":"P\u00e9rez-Pampin","sequence":"additional","affiliation":[]},{"given":"Alfonso","family":"Gonz\u00e1lez-Utrilla","sequence":"additional","affiliation":[]},{"given":"Miguel A.","family":"L\u00f3pez Nevot","sequence":"additional","affiliation":[]},{"given":"Eduardo","family":"Collantes","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o E.","family":"Fonseca","sequence":"additional","affiliation":[]},{"given":"Juan","family":"Sainz","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-1-20210213","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jaut.2012.07.011","article-title":"Heritability versus the role of the environment in autoimmunity.","volume":"39","author":"Selmi","year":"2012","journal-title":"J Autoimmun"},{"key":"R2-1-20210213","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1136\/annrheumdis-2013-204591","article-title":". LifeLines Cohort Study. A genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptides.","volume":"74","author":"Bossini-Castillo","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R3-1-20210213","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/ng.2462","article-title":". High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis.","volume":"44","author":"Eyre","year":"2012","journal-title":"Nat Genet"},{"key":"R4-1-20210213","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/art.38353","article-title":". Novel risk loci for rheumatoid arthritis in Han Chinese and congruence with risk variants in Europeans.","volume":"66","author":"Jiang","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R5-1-20210213","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1136\/annrheumdis-2013-204749","article-title":". High-density genotyping of immune loci in Koreans and Europeans identifies eight new rheumatoid arthritis risk loci.","volume":"74","author":"Kim","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R6-1-20210213","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature12873","article-title":". Genetics of rheumatoid arthritis contributes to biology and drug discovery.","volume":"506","author":"Okada","year":"2014","journal-title":"Nature"},{"key":"R7-1-20210213","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/art.38196","article-title":". Novel rheumatoid arthritis susceptibility locus at 22q12 identified in an extended UK genome-wide association study.","volume":"66","author":"Orozco","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R8-1-20210213","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2217\/pgs.13.60","article-title":". GWAS replication study confirms the association of PDE3A-SLCO1C1 with anti-TNF therapy response in rheumatoid arthritis.","volume":"14","author":"Acosta-Colman","year":"2013","journal-title":"Pharmacogenomics"},{"key":"R9-1-20210213","doi-asserted-by":"crossref","first-page":"e1003394","DOI":"10.1371\/journal.pgen.1003394","article-title":". Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis.","volume":"9","author":"Cui","year":"2013","journal-title":"PLoS Genet"},{"key":"R10-1-20210213","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/art.30130","article-title":". Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci.","volume":"63","author":"Plant","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R11-1-20210213","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/annrheumdis-2012-202405","article-title":". Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis.","volume":"72","author":"Umicevic Mirkov","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R12-1-20210213","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1002\/art.23793","article-title":". Replication of the tumor necrosis factor receptor-associated factor 1complement component 5 region as a susceptibility locus for rheumatoid arthritis in a European family-based study.","volume":"58","author":"Kurreeman","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R13-1-20210213","doi-asserted-by":"crossref","first-page":"e1000107","DOI":"10.1371\/journal.pgen.1000107","article-title":". A large-scale rheumatoid arthritis genetic study identifies association at chromosome 9q33.2.","volume":"4","author":"Chang","year":"2008","journal-title":"PLoS Genet"},{"key":"R14-1-20210213","doi-asserted-by":"crossref","first-page":"e72732","DOI":"10.1371\/journal.pone.0072732","article-title":". Gender-specific effects of genetic variants within Th1 and Th17 cell-mediated immune response genes on the risk of developing rheumatoid arthritis.","volume":"8","author":"Caliz","year":"2013","journal-title":"PLoS One"},{"key":"R15-1-20210213","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/art.38343","article-title":"Increased Th17 cell frequency and poor clinical outcome in rheumatoid arthritis are associated with a genetic variant in the IL4R gene, rs1805010.","volume":"66","author":"Leipe","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R16-1-20210213","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/art.30145","article-title":". The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples.","volume":"63","author":"Rodriguez-Rodriguez","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R17-1-20210213","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1002\/art.24759","article-title":"TRAF1 polymorphisms associated with rheumatoid arthritis susceptibility in Asians and in Caucasians.","volume":"60","author":"Han","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R18-1-20210213","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/art.24503","article-title":"Confirmation of STAT4, IL2IL21, and CTLA4 polymorphisms in rheumatoid arthritis.","volume":"60","author":"Daha","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R19-1-20210213","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/art.24468","article-title":". The PRL -1149 GT polymorphism and rheumatoid arthritis susceptibility.","volume":"60","author":"Lee","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R20-1-20210213","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/art.24244","article-title":". Study of functional variants of the BANK1 gene in rheumatoid arthritis.","volume":"60","author":"Orozco","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R21-1-20210213","first-page":"866","article-title":"Polymorphism of genes related to cardiovascular disease in patients with rheumatoid arthritis.","volume":"25","author":"Arlestig","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"R22-1-20210213","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00296-009-1049-6","article-title":". The -383Agt;C TNFRI polymorphism is associated with soluble levels and clinical activity in rheumatoid arthritis.","volume":"30","author":"Valle","year":"2010","journal-title":"Rheumatol Int"},{"key":"R23-1-20210213","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/art.37938","article-title":". Association of variants in IL2RA with progression of joint destruction in rheumatoid arthritis.","volume":"65","author":"Knevel","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R24-1-20210213","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/art.24721","article-title":". Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis.","volume":"60","author":"Van der Linden","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R25-1-20210213","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/FPC.0b013e328328d51f","article-title":". Investigation of genetic variants within candidate genes of the TNFRSF1B signalling pathway on the response to anti-TNF agents in a UK cohort of rheumatoid arthritis patients.","volume":"19","author":"Bowes","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"R26-1-20210213","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/FPC.0b013e3283544043","article-title":". Investigation of single nucleotide polymorphisms and biological pathways associated with response to TNFalpha inhibitors in patients with rheumatoid arthritis.","volume":"22","author":"Krintel","year":"2012","journal-title":"Pharmacogenet Genomics"},{"key":"R27-1-20210213","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/art.33381","article-title":"Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate. Replication of association of the PTPRC gene with response to anti-tumor necrosis factor therapy in a large UK cohort.","volume":"64","author":"Plant","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R28-1-20210213","first-page":"163","article-title":"Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned Annu Rev I","volume":"19","author":"Feldmann","year":"2001","journal-title":"mmunol"},{"key":"R29-1-20210213","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/1529-0131(200101)44:1<61::AID-ANR9>3.0.CO;2-Q","article-title":"Association between rheumatoid arthritis and polymorphism of tumor necrosis factor receptor II, but not tumor necrosis factor receptor I, in Caucasians.","volume":"44","author":"Barton","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R30-1-20210213","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1002\/art.10592","article-title":"Tumor necrosis factor receptor type II (exon 6) and interleukin-6 (-174) gene polymorphisms are not associated with family history but tumor necrosis factor receptor type II is associated with hypertension in patients with rheumatoid arthritis from northern Sweden.","volume":"46","author":"Dahlqvist","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R31-1-20210213","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00296-010-1478-2","article-title":"Association analysis of TNFR2, VDR, A2M, GSTT1, GSTM1, and ACE genes with rheumatoid arthritis in South Asians and Caucasians of East Midlands in the United Kingdom.","volume":"31","author":"Ghelani","year":"2011","journal-title":"Rheumatol Int"},{"key":"R32-1-20210213","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/ard.2008.106567","article-title":". The TRAF1-C5 region on chromosome 9q33 is associated with multiple autoimmune diseases.","volume":"69","author":"Kurreeman","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R33-1-20210213","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa073491","article-title":". TRAF1-C5 as a risk locus for rheumatoid arthritis - a genomewide study.","volume":"357","author":"Plenge","year":"2007","journal-title":"N Engl J Med"},{"key":"R34-1-20210213","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/ng.2007.32","article-title":". Rheumatoid arthritis association at 6q23.","volume":"39","author":"Thomson","year":"2007","journal-title":"Nat Genet"},{"key":"R35-1-20210213","first-page":"701","article-title":". Association of anti-CCP positivity and carriage of TNFRII susceptibility variant with anti-TNF-alpha response in rheumatoid arthritis.","volume":"29","author":"Vasilopoulos","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"R36-1-20210213","first-page":"340","article-title":"Influence of FCGR3A-V212F and TNFRSF1B-M196R genotypes in patients with rheumatoid arthritis treated with infliximab therapy.","volume":"26","author":"Rooryck","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"R38-1-20210213","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.1074\/jbc.M411541200","article-title":". The Met-196Arg variation of human tumor necrosis factor receptor 2 (TNFR2) affects TNF-alpha-induced apoptosis by impaired NF-kappaB signaling and target gene expression.","volume":"280","author":"Till","year":"2005","journal-title":"J Biol Chem"},{"key":"R39-1-20210213","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1210\/en.2004-1366","article-title":"A polymorphism in the 3 untranslated region of the gene for tumor necrosis factor receptor 2 modulates reporter gene expression.","volume":"146","author":"Puga","year":"2005","journal-title":"Endocrinology"},{"key":"R40-1-20210213","doi-asserted-by":"crossref","first-page":"R1227","DOI":"10.1186\/ar1816","article-title":"Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.","volume":"7","author":"Glossop","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"R41-1-20210213","first-page":"1847","article-title":"Tumor necrosis factor-alpha receptor II polymorphism in patients from southern Europe with mild-moderate and severe rheumatoid arthritis.","volume":"29","author":"Fabris","year":"2002","journal-title":"J Rheumatol"},{"key":"R42-1-20210213","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/rheumatology\/keg267","article-title":"Association of polymorphisms of the tumour necrosis factor receptors I and II and rheumatoid arthritis.","volume":"42","author":"Bayley","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"R43-1-20210213","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/art.20113","article-title":". Tumor necrosis factor receptor II gene polymorphism and severity of rheumatoid arthritis.","volume":"50","author":"Constantin","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R44-1-20210213","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.humimm.2013.09.017","article-title":". Role of TNFRSF1B polymorphisms in the response of Crohns disease patients to infliximab.","volume":"75","author":"Medrano","year":"2014","journal-title":"Hum Immunol"},{"key":"R45-1-20210213","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/ard.2008.088138","article-title":". The tumour necrosis factor receptor superfamily member 1b 676TG polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritis.","volume":"67","author":"Toonen","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R46-1-20210213","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00296-014-3027-x","article-title":"Associations between functional TNFR2 196 MR polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis.","volume":"34","author":"Song","year":"2014","journal-title":"Rheumatol Int"},{"key":"R47-1-20210213","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":". The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"R48-1-20210213","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/art.1780390105","article-title":"Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health OrganizationInternational League Against Rheumatism Criteria.","volume":"39","author":"Van Gestel","year":"1996","journal-title":"Arthritis Rheum"},{"key":"R49-1-20210213","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/1756-0500-2-214","article-title":"SNPtools: a compact tool package for analysis and conversion of genotype data for MS-Excel.","volume":"2","author":"Chen","year":"2009","journal-title":"BMC Res Notes"},{"key":"R50-1-20210213","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/bioinformatics\/btl268","article-title":"SNPStats: a web tool for the analysis of association studies.","volume":"22","author":"Sole","year":"2006","journal-title":"Bioinformatics"},{"key":"R51-1-20210213","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1126\/science.1069424","article-title":". The structure of haplotype blocks in the human genome.","volume":"296","author":"Gabriel","year":"2002","journal-title":"Science"},{"key":"R52-1-20210213","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2119\/2008-00056.Liu","article-title":". Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritis.","volume":"14","author":"Liu","year":"2008","journal-title":"Mol Med"},{"key":"R53-1-20210213","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1136\/ard.2007.074104","article-title":". A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis.","volume":"67","author":"Miceli-Richard","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R54-1-20210213","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1093\/hmg\/ddn245","article-title":". Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis.","volume":"17","author":"Maxwell","year":"2008","journal-title":"Hum Mol Genet"},{"key":"R55-1-20210213","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s00251-001-0423-7","article-title":". Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohns disease, respectively.","volume":"53","author":"Sashio","year":"2002","journal-title":"Immunogenetics"},{"key":"R56-1-20210213","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1002\/art.21200","article-title":"TNFR2 is not associated with rheumatoid arthritis susceptibility in a Caucasian population.","volume":"52","author":"Potter","year":"2005","journal-title":"Arthritis Rheum"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FPC.0000000000000140","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:22:43Z","timestamp":1620951763000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-201507000-00001"}},"subtitle":["a multicenter study"],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":55,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0000000000000140","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}